Skip to content
  • Home
  • Our Company
    • Management
    • Board
    • Medical Advisory Board
  • Pipeline
    • Pipeline
    • OXi4503
    • Collaboration Opportunities
  • PointR Data
  • Press Release
  • Contact Us
IThenaPharma
IThenaPharma

Pipeline

Click HERE for detail presentation

 

Luspatercept reduces transfusion burden in MDS-related anemia: MEDALIST results

  • Contact Us

Copyright © 2019 Oncotelic Inc- a TGF ImmunoOncology Company. All rights reserved.